Warburg Pincus’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Warburg Pincus’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,674	Closed	-$831M	–	10
2016 Q3	$831M	Sell	6,674 -1,305,526	-99%	-$154M	13.45%	3
2016 Q2	$140M	Sell	1,312,200 -2,775,000	-68%	-$322M	3.04%	7
2016 Q1	$468M	Sell	4,087,200 -4,257,000	-51%	-$499M	8.91%	5
2015 Q4	$1.19B	Hold	8,344,200	–	–	21.65%	2
2015 Q3	$749M	Hold	8,344,200	–	–	9.43%	3
2015 Q2	$961M	Sell	8,344,200 -2,645,000	-24%	-$278M	7.67%	5
2015 Q1	$1.05B	Hold	10,989,200	–	–	7.88%	3
2014 Q4	$739M	Hold	10,989,200	–	–	5.1%	5
2014 Q3	$593M	Hold	10,989,200	–	–	3.21%	6
2014 Q2	$489M	Hold	10,989,200	–	–	2.18%	8
2014 Q1	$382M	Hold	10,989,200	–	–	1.69%	10
2013 Q4	$317M	Hold	10,989,200	–	–	3.84%	8
2013 Q3	$321M	Hold	10,989,200	–	–	4.89%	6
2013 Q2	$255M	Buy	+10,989,200	New	+$277M	3.97%	9

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Warburg Pincus's CBPO Position: Q4 2016 in Review

Warburg Pincus sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 6,674 shares — an estimated $831M sold.

Warburg Pincus first reported a position in CBPO in Q2 2013 and held it in 14 quarters. The position peaked at $1.19B in Q4 2015. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

Warburg Pincus reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Warburg Pincus sold 6,674 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $831M.
Warburg Pincus first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 14 quarters.
Warburg Pincus's China Biologic Products Holdings, Inc. position peaked at $1.19B in Q4 2015.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on Warburg Pincus's 13F filing for Q4 2016, filed 14 Feb 2017.